Danske Bank’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
Other funds holding TOVX
Danske Bank's TOVX Position: Q3 2026 in Review
Danske Bank held its Theriva Biologics (TOVX) position steady in Q3 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1225.
Danske Bank first reported a position in TOVX in Q3 2024 and has held it in 9 quarters since. The position peaked at $2 in Q4 2024. 26 funds tracked by Wall St. Rank hold TOVX as of Q3 2026.
- Danske Bank held 1 share of Theriva Biologics worth $0 as of Q3 2026.
- Danske Bank left its Theriva Biologics share count unchanged in Q3 2026.
- Theriva Biologics made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #1225 holding.
- Danske Bank first reported a position in Theriva Biologics in Q3 2024 and has held it in 9 quarters since.
- Danske Bank's Theriva Biologics position peaked at $2 in Q4 2024.
- 26 funds tracked by Wall St. Rank held Theriva Biologics as of Q3 2026.
Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.